Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis

ConclusionsThis case suggests that the individual use of a combination of rituximab and infliximab may be a promising strategy for the treatment in the long term of refractory orbital GPA.
Source: Autoimmunity Highlights - Category: Allergy & Immunology Source Type: research